GENERAL ATLANTIC, L.P.

Q2 2025 13F Holdings

  • Location
    new york, NY
  • Num holdings

    15

  • Value ($000)

    $3,629,524

  • Date Filed
    08/14/2025
  • Form type
    13F-HR
  • CIK
    0001017645
  • All SEC filings
  • Note
    Holdings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q2 2025 to
Select Quarter
Issuer Name
Class
CUSIP
VALUE
%
Shares
Principal
Option Type
---

DLOCAL

CL A
G29018101
$724.70M
20 %

63,906,695

---

CHIME

COM SHS CL A
16935C109
$662.89M
18 %

19,208,760

ALHC
ALHC

ALIGNMENT HEALTHCARE

COM
01625V104
$615.91M
17 %

43,993,323

---

XP, INC

CL A
G98239109
$515.46M
14 %

25,517,733

AKRO
AKRO

AKERO THERAPEUTICS

COM
00973Y108
$305.97M
8 %

5,733,989

ALKT
ALKT

ALKAMI

COM
01644J108
$290.71M
8 %

9,645,318

---

PHARVARIS

COM
N69605108
$132.55M
4 %

7,531,252

CNTA
CNTA

CENTESSA PHARMACEUTICALS

ADS
152309100
$127.22M
4 %

9,681,818

---

WEBULL

ORD SHS
G9572D103
$85.49M
2 %

7,148,051

EWCZ
EWCZ

EUROPEAN WAX CENTER

CL A
29882P106
$73.81M
2 %

13,110,492

Rows Per Page
10
  • 10
  • 50
  • 100
1 - 10 of 15